Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

dinutuximab MeSH Supplementary Concept Data 2025


MeSH Supplementary
dinutuximab
Unique ID
C112746
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C112746
Entry Term(s)
APN-311
APN311
CH-14.18
CH-14.18-UTC
CH14.18-UTC
MAb ch14.18
ch14.18
ch14.18 monoclonal antibody
dinutuximab beta
monoclonal antibody ch14.18
unituxin
Pharm Action
Antineoplastic Agents
Registry Numbers
7SQY4ZUD30
Heading Mapped to
*Antibodies, Monoclonal
Frequency
120
Note
a human-mouse chimeric monoclonal antibody directed against disialoganglioside (GD2); used for treatment of refractory neuroblastoma & osteosarcoma
Source
J Clin Oncol 1998 Jun;16(6):2169-80
Date of Entry
1998/06/30
Revision Date
2024/03/15
dinutuximab Preferred
ch14.18 Narrower
APN-311 Narrower
unituxin Narrower
dinutuximab beta Narrower
page delivered in 0.006s